FibroGen, Inc. (FGEN)
NASDAQ: FGEN · Real-Time Price · USD
0.2914
-0.0267 (-8.39%)
May 6, 2025, 2:09 PM EDT - Market open
FibroGen Stock Forecast
FGEN's stock price has decreased by -72.1% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 1 analyst with a 12-month price forecast for FibroGen stock has a target of 10, which predicts an increase of 3,331.71% from the current stock price of 0.29.
Analyst Consensus: Strong Buy
* Price targets were last updated on Mar 18, 2025.
Analyst Ratings
According to 1 stock analyst, the rating for FibroGen is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 4 | 4 | 0 | 0 | 0 | 0 |
| Sell | 1 | 1 | 0 | 0 | 0 | 0 |
| Strong Sell | 1 | 1 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 1 | 1 | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +3,331.71% | Mar 18, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +3,331.71% | Feb 20, 2025 |
| B of A Securities | B of A Securities | Hold → Sell Downgrades $4 → $2 | Hold → Sell | Downgrades | $4 → $2 | +586.34% | Aug 8, 2023 |
| Goldman Sachs | Goldman Sachs | Strong Sell Maintains $16 → $2 | Strong Sell | Maintains | $16 → $2 | +586.34% | Jun 27, 2023 |
| Raymond James | Raymond James | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Jun 27, 2023 |
Financial Forecast
Revenue This Year
98.58M
from 29.62M
Increased by 232.81%
Revenue Next Year
107.61M
from 98.58M
Increased by 9.16%
EPS This Year
-0.72
from -0.48
EPS Next Year
-0.72
from -0.72
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 196.7M | 215.3M | 248.5M | |
| Avg | 98.6M | 107.6M | 123.8M | |
| Low | 5.9M | 5.9M | 5.9M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 564.0% | 118.3% | 131.0% | |
| Avg | 232.8% | 9.2% | 15.0% | |
| Low | -80.1% | -94.0% | -94.5% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | -0.56 | -0.59 | -0.46 | |
| Avg | -0.72 | -0.72 | -0.59 | |
| Low | -0.86 | -0.84 | -0.71 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | - | - | - | |
| Avg | - | - | - | |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.